Diagnostic génétique du LPAC – JAMRF25

Diagnostic génétique du LPAC – JAMRF25

by Dr Philippe Couvert

Life & Natural Systems Medicine & Health MFPre-clinical medicine: basic sciencesMFNMedical genetics
🎙 Dr Philippe Couvert 👥 2K 📅 February 19, 2026 ⏱ 16 min 👁 58 📄 original study 🧭 2026-08-16
Available in: English (current) Français

Keywords

LPACABCB4ABCG8genetic diagnosisintrahepatic lithiasis

Summary

Dr Philippe Couvert presents the genetic diagnosis of LPAC (Low Phospholipid Associated Cholelithiasis) during the 2025 Annual Rare Liver Diseases Days. He begins by recalling the main diagnostic criteria: symptoms before age 40, recurrence after cholecystectomy, and intrahepatic lithiasis on imaging. He then describes his extended criteria, including secondary criteria such as history of intrahepatic cholestasis of pregnancy, cholecystectomy before age 40 in a first-degree relative, and pain relief under UDCA. He presents data from over 1000 patients, of which 804 are classified as LPAC, 124 as extended criteria, and 84 as intrahepatic lithiasis only. He analyzes mutations in ABCB4, finding loss-of-function variants in about 4.2% of alleles, enriched compared to general population. He also discusses missense variants and VUS, highlighting the importance of population-specific frequencies. He then focuses on the ABCG8 D19H variant, a gain-of-function variant associated with increased cholesterol secretion into bile, which is overrepresented in LPAC patients and acts as a risk factor. He also reports duplications and triplications of the ABCG5/ABCG8 locus. He concludes that ABCG8 variants contribute to about 2-3% of LPAC cases, while ABCB11 is not a major gene. He emphasizes that many intrahepatic lithiasis cases remain genetically unexplained, suggesting a polygenic or environmental component. He ends by thanking the association Alby for funding future research.

212 words

Critical Evaluation

Value of the Information & Strength of the Argument

The presentation provides valuable original data from a large cohort, offering insights into the genetic architecture of LPAC. The speaker systematically compares allele frequencies in LPAC patients with controls (GenomAD and a dyslipidemia cohort) to distinguish true pathogenic variants from polymorphisms. He demonstrates the importance of population-specific frequencies, as exemplified by the R788Q variant. The argumentation is solid, using enrichment factors and functional data to support conclusions. However, some findings are preliminary and not yet peer-reviewed, and the speaker acknowledges limitations such as small sample sizes for certain subgroups.

Scientific Rigor, Source Quality, Title Accuracy

The presentation is scientifically rigorous, with clear methodology and appropriate use of control groups. The speaker cites specific studies (e.g., the 2013 paper by Poupon’s team) and databases (GenomAD, ClinVar) to support his interpretations. The title accurately reflects the content. The talk is part of a professional conference, indicating a high level of expertise. No comments were provided for analysis.

164 words

Title / Content Match

The title accurately reflects the content, which focuses on genetic diagnosis of LPAC.

Quality & Reliability

8/10

Presentation of original data from a large cohort (804 LPAC patients) with detailed genetic analysis, including comparison with control groups and functional considerations. The speaker is a medical doctor specialized in genetics, and the talk is part of a professional conference. Limitations include lack of peer review and some preliminary findings.

Key Moments

Markers derived by PSI from the transcript: the creator did not define chapters.

Cited Sources

  • FILFOIE website — Organization of the conference and resource for rare liver diseases

Concurring Sources

  • GenomAD — Used as a control population for allele frequencies

Dissenting Sources

  • ClinVar — Some variants classified as benign or likely benign in ClinVar were considered polymorphic by the speaker, leading to their exclusion from analysis.

Contribution & Novelties

This presentation provides novel insights into the genetic basis of LPAC, particularly the role of ABCG8 variants and the importance of population-specific allele frequencies. The speaker’s extended criteria and classification of patients may improve diagnostic accuracy. The finding that ABCG8 D19H is a risk factor for LPAC and that homozygous D19H can mimic ABCB4 mutations is a significant contribution. The identification of copy number variations in ABCG5/ABCG8 adds to the mutational spectrum.

Pour aller plus loin :

105 words

Radar Profile

The radar profile shows high scores in quantity and quality of information, reflecting the detailed genetic analysis and large cohort. The technical level is also high, indicating a specialized audience. The global reliability is strong, though not perfect due to the preliminary nature of some findings.

Reliability 8/10